Agents in Development for Dementia Syndromes in Japan
- 期刊名称Drugs in R&D
- 作者Kate Palmer,Joanne Dalton
- 卷第2卷
- 期第2期
- 印刷ISSN1174-5886
- 电子ISSN1179-6901
- 文件大小77.54KB
- 发表时间1999-08
- DOI10.2165/00126839-199902020-00012
- 页码129-132
Desmethyl bosentan displays a similar in vitro interaction profile as bosentanWeiss, Johanna; Baumann, Sybille; Theile, Dirk; Haefeli, Walter Emil · Pulmonary Pharmacology & Therapeutics · 2015
COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL COMPARED WITH BOSENTAN ALONE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSIONAl-Sharif, Hassan; Bshouty, Zoheir · Chest · 2006
Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reportsTomoki Ito,Yoshio Ozaki,Yonsu Son,Tohru Nishizawa… · Journal of Medical Case Reports · 2014
Consecutive use of sildenafil and bosentan for the treatment of pulmonary arterial hypertension associated with collagen vascular disease: sildenafil as reliever and bosentan as controllerKamata, Y.; Iwamoto, M.; Minota, S. · Lupus · 2007
Comparison of the Inhibitory Effect of Ketoconazole, Voriconazole, Fluconazole, and Itraconazole on the Pharmacokinetics of Bosentan and Its Corresponding Active Metabolite Hydroxy Bosentan in RatsChen, Mengchun; Zhang, Xufei; Chen, Yijie; Sun, Wei; Wang, Zhe; Huang, Chengke; Hu, Guoxin; Chen, Ruijie · Xenobiotica · 2019
Delayed hypersensitivity to bosentanA. Romano; A. Giovannetti; C. Caruso; E. Rosato; M. Pierdominici; F. Salsano · 2009
La découverte du bosentanM. Clozel · 2007
Bosentan in mild pulmonary hypertensionGeorgios Giannakoulas; Konstantinos Dimopoulos; Michael A Gatzoulis · 2008
Neramexane&NA; · Drugs in R & D · 2002
Acknowledgement to RefereesAnton van Rensburg · Drugs in R&D · 2013
Etravirine&NA;, · Drugs in R & D · 2006
Transplant RejectionStephen G. Coleman,Richelle Paterson · Drugs in R&D · 1999
BTI 322Drugs in R&D · 1999
Campath-1GDrugs in R&D · 1999
CHH 380Drugs in R&D · 1999
EtanerceptDrugs in R&D · 1999